Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-α in patients with chronic hepatitis B
Authors:
- 27 June 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 79 (1) , 167-182
Abstract
Background and Aims: Chronic hepatitis B (CHB) is caused by hepatitis B virus (HBV) infection and affects the lives of millions of people worldwide by causing liver inflammation, cirrhosis and liver cancer. Interferon-alpha (IFN-α) therapy is a conventional immunotherapy that has been widely used in CHB treatment and achieved promising therapeutic outcomes by activating viral sensors and interferon-stimulated genes (ISGs) suppressed by HBV. However, the longitudinal landscape of immune cells of CHB patients and the effect of IFN-α on the immune system are not fully understood. Approach and Results: Here, we applied single-cell RNA sequencing (scRNA-seq) to delineate the transcriptomic landscape of peripheral immune cells in CHB patients before and after PegIFN-α therapy. Notably, we identified three CHB-specific cell subsets, Pro-infla CD14 + monocytes, Pro-infla CD16 + monocytes and IFN + CX3CR1- NK cells, which highly expressed pro-inflammatory genes and positively correlated with HBsAg. Furthermore, PegIFN-α treatment attenuated percentages of hyperactivated monocytes, increased ratios of long-lived naive/memory T cells and enhanced effector T cell cytotoxicity. Finally, PegIFN-α treatment switched the transcriptional profiles of entire immune cells from TNF-driven to IFN-α-driven pattern and enhanced innate antiviral response, including virus sensing and antigen presentation. Conclusions: Collectively, our study expands the understanding of the pathological characteristics of CHB and the immunoregulatory roles of PegIFN-α, which provides a new powerful reference for the clinical diagnosis and treatment of CHB. ExportKeywords
This publication has 40 references indexed in Scilit:
- Negative Regulation of Type I IFN Expression by OASL1 Permits Chronic Viral Infection and CD8+ T-Cell ExhaustionPLOS Pathogens, 2013
- Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis BJournal of Hepatology, 2013
- Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis BPLOS ONE, 2012
- IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processingBlood, 2012
- Early Changes in Interferon Signaling Define Natural Killer Cell Response and Refractoriness to Interferon–Based Therapy of Hepatitis C PatientsHepatology, 2011
- Altered interferon-α-signaling in natural killer cells from patients with chronic hepatitis C virus infectionJournal of Hepatology, 2010
- EASL Clinical Practice Guidelines: Management of chronic hepatitis BJournal of Hepatology, 2009
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis BNew England Journal of Medicine, 2008
- Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infectionJournal of Clinical Investigation, 2006
- Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?Current Opinion in Microbiology, 2000